MicroRNA-103 regulates tumorigenesis in colorectal cancer by targeting ZO-1

16Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Given the emerging role of MicroRNAs (miRs) in cancer progression, the present study investigated the role and underlying mechanism of miR-103 in colorectal cancer (CRC). Reverse transcription-quantitative polymerase chain reaction was conducted to quantify the expression levels of miR-103 in clinical specimens and cell lines. The role of miR-103 in CRC was examined using MTT, colony formation and tran-swell assays. In addition, a luciferase reporter assay was used to confirm an associated between the 3' untranslated region of zonula occuldens-1 (ZO-1) and miR-103. The results demonstrated that miR-103 was upregulated in CRC. Overexpression of miR-103 promoted CRC cell proliferation and migration in vitro, whereas downregulation of miR-103 inhibited cell proliferation and migration. ZO-1 was identified as a direct target of miR-103, revealing its expression to be inversely correlated with miR-103 expression in CRC samples. In conclusion, the present study revealed that miR-103 has strong tumor-promoting effects via of targeting ZO-1 in CRC and has potential development of miRNA-based targeted approaches for the treatment of CRC.

Cite

CITATION STYLE

APA

Ke, J., Shao, W., Jiang, Y., Xu, J., Li, F., & Qin, J. (2018). MicroRNA-103 regulates tumorigenesis in colorectal cancer by targeting ZO-1. Molecular Medicine Reports, 17(1), 783–788. https://doi.org/10.3892/mmr.2017.8007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free